Accellix Raises $10 Million From BroadOak Capital Partners
Accellix will use the investment to expand its commercial resources and infrastructure in support of its cell therapy customers Accellix Inc., which provides quick and accurate flow cytometry results in a compact and easy-to-use platform designed for use by cell therapy companies on the manufacturing floor and at the point-of-need,......